← Back to Search

Unknown

Manapol for Microbiome

N/A
Waitlist Available
Led By Richard Bloomer, PhD
Research Sponsored by University of Memphis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on day 30 of treatment
Awards & highlights

Study Summary

The present study will compare the effect of Manapol to DaltonMax on select measures of health. Currently, both ingredients are sold both as a stand-alone dietary supplement and as an active ingredient within various multi-nutrient products. Immune function will be assessed using blood samples to determine white blood cell counts and distributions, and cytokine levels with/without lipopolysaccharide (LPS) challenge. Additionally, effects specific to antioxidant function and glucose regulation, glucose, insulin, lipid peroxidation, and advanced oxidation protein products will be observed. Antioxidant capacity will also be measured. as well as completion of weekly questionnaires regarding gut health, and microbiome analysis.

Eligible Conditions
  • Microbiome
  • Immune System

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on day 30 of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and on day 30 of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Advanced oxidation protein products
Antioxidants
Cytokine Panel for plasma
+8 more
Secondary outcome measures
Food Logs
Resting Blood Pressure
Resting Heart Rate

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: ManapolExperimental Treatment1 Intervention
1000 mg (Manapol only) Aloe Vera extract daily
Group II: Dalton MaxExperimental Treatment1 Intervention
1000 mg (Dalton Max only) Aloe Vera extract daily
Group III: PlaceboPlacebo Group1 Intervention
Placebo (rice dextrin or similar) taken daily
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aloe Vera Extract 2
2022
N/A
~60
Aloe Vera Extract 1
2022
N/A
~60

Find a Location

Who is running the clinical trial?

MannatechUNKNOWN
University of MemphisLead Sponsor
70 Previous Clinical Trials
11,829 Total Patients Enrolled
Richard Bloomer, PhDPrincipal InvestigatorUniversity of Memphis
16 Previous Clinical Trials
429 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~21 spots leftby Apr 2025